<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>OrthoSpineNews &#187; Biologics</title>
	<atom:link href="http://www.orthospinenews.com/category/biologics/feed" rel="self" type="application/rss+xml" />
	<link>http://www.orthospinenews.com</link>
	<description>The latest news for the orthopedic and spine industries</description>
	<lastBuildDate>Fri, 03 Feb 2012 17:40:08 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>BioRestorative Therapies Signs License Agreement for Stem Cell Disc/Spine Procedure</title>
		<link>http://www.orthospinenews.com/biorestorative-therapies-signs-license-agreement-for-stem-cell-discspine-procedure</link>
		<comments>http://www.orthospinenews.com/biorestorative-therapies-signs-license-agreement-for-stem-cell-discspine-procedure#comments</comments>
		<pubDate>Wed, 01 Feb 2012 16:36:31 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[Agreement]]></category>
		<category><![CDATA[biorestorative]]></category>
		<category><![CDATA[license]]></category>
		<category><![CDATA[Stem Cell]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=6213</guid>
		<description><![CDATA[JUPITER, Fla., Jan. 31, 2012 /PRNewswire/ -- BioRestorative Therapies, Inc. (OTCQB: BRTX) ("BRT") today announced that it has entered into a License Agreement with Regenerative Sciences, LLC ("RS") with respect to certain stem cell-related technology and clinical treatment procedures developed by RS. The ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/biorestorative-therapies-signs-license-agreement-for-stem-cell-discspine-procedure/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>An Inteview with Paul Nichols</title>
		<link>http://www.orthospinenews.com/an-inteview-with-paul-nichols</link>
		<comments>http://www.orthospinenews.com/an-inteview-with-paul-nichols#comments</comments>
		<pubDate>Mon, 30 Jan 2012 17:16:54 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[bio2]]></category>
		<category><![CDATA[healthpoint capital]]></category>
		<category><![CDATA[interview]]></category>
		<category><![CDATA[paul nichols]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=6177</guid>
		<description><![CDATA[We recently spoke with Paul Nichols, the current Executive Chairman of Bio2 Technologies who formerly worked with HealthpointCapital as President and CEO of Nexa Orthopedics. Learn what he has to say about the opportunities and challenges of the musculoskeletal industry ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/an-inteview-with-paul-nichols/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Geron Selling Off Embryonic Stem Cell Technology</title>
		<link>http://www.orthospinenews.com/geron-selling-off-embryonic-stem-cell-technology</link>
		<comments>http://www.orthospinenews.com/geron-selling-off-embryonic-stem-cell-technology#comments</comments>
		<pubDate>Mon, 23 Jan 2012 17:05:43 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[divest]]></category>
		<category><![CDATA[geron]]></category>
		<category><![CDATA[ry ortho]]></category>
		<category><![CDATA[selling]]></category>
		<category><![CDATA[Stem Cell]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=6167</guid>
		<description><![CDATA[After nearly $450 million of equity raised and a record breaking $40 million FDA submission, Geron is throwing in the towel regarding its ground breaking embryonic stem cell therapy to treat nerve damaged patients. Under the FDA trial, Geron had ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/geron-selling-off-embryonic-stem-cell-technology/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pioneer® Surgical Technology, Inc. Announces the Expansion of its North Carolina Biomanufacturing Facility</title>
		<link>http://www.orthospinenews.com/pioneer-surgical-technology-inc-announces-the-expansion-of-its-north-carolina-biomanufacturing-facility</link>
		<comments>http://www.orthospinenews.com/pioneer-surgical-technology-inc-announces-the-expansion-of-its-north-carolina-biomanufacturing-facility#comments</comments>
		<pubDate>Mon, 23 Jan 2012 17:04:47 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[Expansion]]></category>
		<category><![CDATA[growth]]></category>
		<category><![CDATA[Pioneer Surgical]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=6165</guid>
		<description><![CDATA[Pioneer Surgical Technology today announces the grand opening of its newly expanded Greenville manufacturing facility. The location houses the primary manufacturing operations for Pioneer Surgical’s biologic products sold in the United States and Europe. Regarding Pioneer’s latest expansion, Mr. Shane Ray, ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/pioneer-surgical-technology-inc-announces-the-expansion-of-its-north-carolina-biomanufacturing-facility/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA approval of BioMimetic’s Augment Bone Graft dependent on more information</title>
		<link>http://www.orthospinenews.com/fda-approval-of-biomimetics-augment-bone-graft-dependent-on-more-information</link>
		<comments>http://www.orthospinenews.com/fda-approval-of-biomimetics-augment-bone-graft-dependent-on-more-information#comments</comments>
		<pubDate>Thu, 12 Jan 2012 15:21:28 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[Biomimetic]]></category>
		<category><![CDATA[Bone Graft]]></category>
		<category><![CDATA[ortho supersite]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=6086</guid>
		<description><![CDATA[In a post-panel response letter, the FDA told BioMimetic Therapeutics Inc. that it would need to submit more information about the safety and efficacy of its Augment Bone Graft in order to receive premarket approval. According to a press release, ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/fda-approval-of-biomimetics-augment-bone-graft-dependent-on-more-information/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Judge grants Ex-Stryker Biotech exec&#8217;s request to sever charges in fraud case</title>
		<link>http://www.orthospinenews.com/judge-grants-ex-stryker-biotech-execs-request-to-sever-charges-in-fraud-case</link>
		<comments>http://www.orthospinenews.com/judge-grants-ex-stryker-biotech-execs-request-to-sever-charges-in-fraud-case#comments</comments>
		<pubDate>Wed, 11 Jan 2012 23:02:34 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[court]]></category>
		<category><![CDATA[fraud]]></category>
		<category><![CDATA[jail]]></category>
		<category><![CDATA[litigation]]></category>
		<category><![CDATA[op1]]></category>
		<category><![CDATA[Stryker]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=6081</guid>
		<description><![CDATA[A Massachusetts federal judge grants former Stryker Biotech exec Mark Philip a motion to sever charges against him in federal beef alleging that the company illegally promoted off-label use of combination of two bone growth products and lied to the ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/judge-grants-ex-stryker-biotech-execs-request-to-sever-charges-in-fraud-case/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MiMedx Group, Inc. Receives CE Certification for Its CollaFix™ Surgical Mesh CD</title>
		<link>http://www.orthospinenews.com/mimedx-group-inc-receives-ce-certification-for-its-collafix-surgical-mesh-cd</link>
		<comments>http://www.orthospinenews.com/mimedx-group-inc-receives-ce-certification-for-its-collafix-surgical-mesh-cd#comments</comments>
		<pubDate>Wed, 11 Jan 2012 16:01:52 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[CE Mark]]></category>
		<category><![CDATA[europe]]></category>
		<category><![CDATA[milestone]]></category>
		<category><![CDATA[MiMedx]]></category>
		<category><![CDATA[Product Launch]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=6053</guid>
		<description><![CDATA[KENNESAW, Ga., Jan. 10, 2012 -- /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it has received the certification for the Company's ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/mimedx-group-inc-receives-ce-certification-for-its-collafix-surgical-mesh-cd/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cascade Medical Enterprises, LLC Announces the Sale of Their Orthopedic Business</title>
		<link>http://www.orthospinenews.com/cascade-medical-enterprises-llc-announces-the-sale-of-their-orthopedic-business</link>
		<comments>http://www.orthospinenews.com/cascade-medical-enterprises-llc-announces-the-sale-of-their-orthopedic-business#comments</comments>
		<pubDate>Fri, 06 Jan 2012 16:13:01 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[acquisition]]></category>
		<category><![CDATA[cascade]]></category>
		<category><![CDATA[sale]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=6039</guid>
		<description><![CDATA[WAYNE, N.J., Jan. 6, 2012 /PRNewswire via COMTEX/ -- Cascade Medical Enterprises, LLC (CME), a leading company with proprietary platelet-rich plasma (PRP) and platelet-rich fibrin matrix (PRFM) technology for use in orthopedic therapeutic applications in soft tissue and bone repair, ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/cascade-medical-enterprises-llc-announces-the-sale-of-their-orthopedic-business/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pioneer® Surgical Announces First Human Use of nanOss® Bioactive 3D</title>
		<link>http://www.orthospinenews.com/pioneer-surgical-announces-first-human-use-of-nanoss-bioactive-3d</link>
		<comments>http://www.orthospinenews.com/pioneer-surgical-announces-first-human-use-of-nanoss-bioactive-3d#comments</comments>
		<pubDate>Thu, 05 Jan 2012 16:16:10 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[milestone]]></category>
		<category><![CDATA[new product]]></category>
		<category><![CDATA[Pioneer Surgical]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=6027</guid>
		<description><![CDATA[Pioneer Surgical today announces the first clinical use ofnanOss Bioactive 3D, a three-dimensionally shaped addition to its flagship biologic bone graft product line, nanOss Bioactive. The new nanOss Bioactive 3D bone graft utilizes proprietary nanocrystalline hydroxyapatite as well as a ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/pioneer-surgical-announces-first-human-use-of-nanoss-bioactive-3d/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>SNN spins out biologics unit in JV with Essex Woodlands</title>
		<link>http://www.orthospinenews.com/snn-spins-out-biologics-unit-in-jv-with-essex-woodlands</link>
		<comments>http://www.orthospinenews.com/snn-spins-out-biologics-unit-in-jv-with-essex-woodlands#comments</comments>
		<pubDate>Wed, 04 Jan 2012 16:42:16 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[divest]]></category>
		<category><![CDATA[essex woodlands]]></category>
		<category><![CDATA[snn]]></category>
		<category><![CDATA[spin out]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=6017</guid>
		<description><![CDATA[British orthopedic titan Smith &#38; Nephew (NYSE:SNN) shuffled its business deck yet again with the spinout of its biologics and clinical therapies division in a joint venture with venture capital firm Essex Woodlands. Essex will own 51% of the new ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/snn-spins-out-biologics-unit-in-jv-with-essex-woodlands/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA seeks more info from BioMimetic</title>
		<link>http://www.orthospinenews.com/fda-seeks-more-info-from-biomimetic</link>
		<comments>http://www.orthospinenews.com/fda-seeks-more-info-from-biomimetic#comments</comments>
		<pubDate>Wed, 04 Jan 2012 16:40:24 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[510k]]></category>
		<category><![CDATA[Biomimetic]]></category>
		<category><![CDATA[FDA]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=6013</guid>
		<description><![CDATA[BioMimetic Therapeutics Inc. (Nasdaq: BMTI) was dealt a setback Tuesday when it learned the Food and Drug Administration    did not approve its application for the bone graft device Augment, and has requested additional clinical information from the company. BioMimetic had been aiming for FDA ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/fda-seeks-more-info-from-biomimetic/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Isis, Biogen Strike Potential $299M Deal For Rare Spine Disorder Treatment</title>
		<link>http://www.orthospinenews.com/isis-biogen-strike-potential-299m-deal-for-rare-spine-disorder-treatment</link>
		<comments>http://www.orthospinenews.com/isis-biogen-strike-potential-299m-deal-for-rare-spine-disorder-treatment#comments</comments>
		<pubDate>Wed, 04 Jan 2012 16:36:20 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[acquisition]]></category>
		<category><![CDATA[biogen]]></category>
		<category><![CDATA[isis]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=6008</guid>
		<description><![CDATA[Isis Pharmaceuticals has found a new partner in Biogen Idec that’s betting a large amount of money on a new therapy for a rare spinal disorder in newborns. Weston, MA-based Biogen Idec (NASDAQ: BIIB)said today that it has agreed to work with Carlsbad, CA-based Isis Pharmaceuticals (NASDAQ: ISIS) ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/isis-biogen-strike-potential-299m-deal-for-rare-spine-disorder-treatment/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Senators press Medtronic for device info</title>
		<link>http://www.orthospinenews.com/senators-press-medtronic-for-device-info</link>
		<comments>http://www.orthospinenews.com/senators-press-medtronic-for-device-info#comments</comments>
		<pubDate>Tue, 20 Dec 2011 16:39:42 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[infuse]]></category>
		<category><![CDATA[medtronic]]></category>
		<category><![CDATA[senators]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=5983</guid>
		<description><![CDATA[WASHINGTON - Three U.S. senators have asked Fridley-based Medtronic Inc. to supply detailed information about how the company keeps track of its medical devices after they go to market. In a six-page letter that strikes an investigational tone, Sens. Charles ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/senators-press-medtronic-for-device-info/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Baxter to acquire Synovis</title>
		<link>http://www.orthospinenews.com/baxter-to-acquire-synovis</link>
		<comments>http://www.orthospinenews.com/baxter-to-acquire-synovis#comments</comments>
		<pubDate>Wed, 14 Dec 2011 16:32:21 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[acquire]]></category>
		<category><![CDATA[acquisition]]></category>
		<category><![CDATA[baxter]]></category>
		<category><![CDATA[synovis]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=5922</guid>
		<description><![CDATA[Baxter International Inc. (NYSE:BAX) and Synovis Life Technologies, Inc. (NASDAQ:SYNO) today announced a definitive agreement for Baxter to acquire Synovis, a leading provider of biological and mechanical products for soft tissue repair used in a variety of surgical procedures. The ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/baxter-to-acquire-synovis/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Update: Two ex-Synthes executives, Michael Huggins and Thomas Higgins, get 9 months in prison</title>
		<link>http://www.orthospinenews.com/update-two-ex-synthes-executives-michael-huggins-and-thomas-higgins-get-9-months-in-prison</link>
		<comments>http://www.orthospinenews.com/update-two-ex-synthes-executives-michael-huggins-and-thomas-higgins-get-9-months-in-prison#comments</comments>
		<pubDate>Mon, 21 Nov 2011 21:23:04 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[featured]]></category>
		<category><![CDATA[higgins]]></category>
		<category><![CDATA[huggins]]></category>
		<category><![CDATA[jail]]></category>
		<category><![CDATA[pictures]]></category>
		<category><![CDATA[Synthes]]></category>
		<category><![CDATA[verdict]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=5856</guid>
		<description><![CDATA[UPDATE 3 p.m.: At about 2:45 p.m., Brent Gurney, the attorney for Richard Bohner, collapsed while standing at a lectern discussing his client with Judge Davis. Gurney was bleeding from his head, apparently having hit a nearby table as he ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/update-two-ex-synthes-executives-michael-huggins-and-thomas-higgins-get-9-months-in-prison/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

